GlassScriptPhysician profile
Roy B Mukku
NPI 1265722102
$25,877.18
in general payments reported to CMS, 2019-2025
35 companies · $7,568 in 2025
The $7,568 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,800 · 2020: $8,181 · 2021: $785 · 2022: $1,776 · 2023: $1,401 · 2024: $2,367 · 2025: $7,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,787 · Travel and Lodging: $3,549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,786.82 |
| Travel and Lodging | $3,548.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,184.29 | 2019-2020 | |
| Medtronic, INC. | $4,707.66 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Edwards Lifesciences Corporation | $2,274.91 | 2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $2,065.17 | 2019-2025 | Emerge Push, Emblem Mri S-Icd, Opticross 6 |
| Abbott Laboratories | $1,953.85 | 2019-2025 | Navitor, Coroflow, Pressurewire |
| Abiomed | $1,131.54 | 2020-2025 | Impella |
| Shockwave Medical, INC | $1,015.65 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $954.99 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $777.85 | 2019-2025 | |
| Acist Medical Systems, INC. | $754.02 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $710.53 | 2019-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $609.84 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $487.58 | 2019-2025 | Farxiga, Brilinta |
| Penumbra, INC. | $382.06 | 2022-2023 | Indigo System |
| Pfizer INC. | $349.93 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $335.72 | 2019-2025 | Camzyos, Eliquis |
| Astellas Pharma US INC | $262.93 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.06 | 2019-2025 | Jardiance |
| Chiesi USA, INC. | $211.35 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $174.72 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $136.36 | 2019-2024 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $126.31 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2019 | |
| Novo Nordisk INC | $125.00 | 2025 | |
| Irhythm Technologies, INC. | $122.52 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Lexicon Pharmaceuticals, INC. | $109.29 | 2023-2024 | Inpefa |
| Lantheus Medical Imaging, INC. | $108.79 | 2022-2024 | Definity |
| Sanofi-Aventis U.S. LLC | $104.28 | 2019 | |
| Philips North America LLC | $69.96 | 2020 | |
| Esperion Therapeutics, INC. | $69.79 | 2023-2024 | Nexletol |
| Lundbeck LLC | $63.32 | 2019 | |
| Heartflow, INC. | $62.83 | 2019-2025 | |
| Cvrx, INC. | $26.48 | 2024 | Barostim Neo System |
| Cathworks, INC. | $26.32 | 2020 | |
| Ge Healthcare | $22.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Mukku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.